Clinical Laserthermia Systems AB (FRA:LS60) Cyclically Adjusted PS Ratio: (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LS60 Clinical Laserthermia Systems AB FRA:LS60
42 GF Score
Price €0.24
GF Value €0.28
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Clinical Laserthermia Systems AB Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Clinical Laserthermia Systems AB  (FRA:LS60) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Clinical Laserthermia Systems AB Cyclically Adjusted PS Ratio Related Terms


Clinical Laserthermia Systems AB Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Clinical Laserthermia Systems AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinical Laserthermia Systems AB Cyclically Adjusted PS Ratio Chart

Clinical Laserthermia Systems AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 129.68 22.27 10.68 1.53 2.93

Clinical Laserthermia Systems AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 3.84 2.93 1.97 0.00

FRA:LS60 vs ABT, SYK, MDT: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Clinical Laserthermia Systems AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinical Laserthermia Systems AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Clinical Laserthermia Systems AB's Cyclically Adjusted PS Ratio falls into.


FRA:LS60
42GF Score
Clinical Laserthermia Systems AB FRA:LS60
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinical Laserthermia Systems AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Clinical Laserthermia Systems AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Clinical Laserthermia Systems AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.022/134.1100*134.1100
=0.022

Current CPI (Jun. 2026) = 134.1100.

Clinical Laserthermia Systems AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.000 101.138 0.000
201612 0.000 102.022 0.000
201703 0.000 102.022 0.000
201706 0.000 102.752 0.000
201709 0.042 103.279 0.055
201712 0.052 103.793 0.067
201803 0.067 103.962 0.086
201806 0.116 104.875 0.148
201809 0.018 105.679 0.023
201812 0.054 105.912 0.068
201903 0.014 105.886 0.018
201906 0.035 106.742 0.044
201909 0.123 107.214 0.154
201912 0.015 107.766 0.019
202003 0.027 106.563 0.034
202006 0.032 107.498 0.040
202009 0.088 107.635 0.110
202012 -0.004 108.296 -0.005
202103 0.099 108.360 0.123
202106 0.000 108.928 0.000
202109 0.001 110.338 0.001
202112 0.101 112.486 0.120
202203 0.064 114.825 0.075
202206 0.033 118.384 0.037
202209 0.041 122.296 0.045
202212 0.188 126.365 0.200
202303 0.020 127.042 0.021
202306 0.041 129.407 0.042
202309 0.033 130.224 0.034
202312 0.060 131.912 0.061
202403 0.042 132.205 0.043
202406 0.036 132.716 0.036
202409 0.037 132.304 0.038
202412 0.028 132.987 0.028
202503 0.019 132.825 0.019
202506 0.033 133.699 0.033
202509 0.010 133.480 0.010
202512 0.002 133.390 0.002
202603 0.004 133.560 0.004
202606 0.022 134.110 0.022

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?

Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued. The current stock price of €0.24 is trading 12.9% below its estimated GF Value™ of €0.28. GuruFocus considers Clinical Laserthermia Systems AB to be Modestly Undervalued.

Key valuation signals for FRA:LS60:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €0.28 vs. price of €0.24 (12.9% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinical Laserthermia Systems AB Business Description

Other Exchanges CLS B:Sweden
Address Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
42GF Score

Get the complete analysis for FRA:LS60

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.24
Price
€0.28
GF Value